Association of killer cell immunoglobulin‐like receptors with scleroderma

Open Access

6 May 2004

journal article
research article
Published by Wiley in Arthritis & Rheumatism

Vol. 50 (5) , 1561-1565
https://doi.org/10.1002/art.20216

Abstract

Objective: Scleroderma is an autoimmune disorder of unknown etiology. A genetic contribution has been demonstrated, and genes influencing activation of the immune system have been potentially identified as candidate genes in this process. The repertoire of killer cell immunoglobulin‐like receptors (KIRs) that are involved in the activation of T cells and natural killer cells is highly variable. Recently, an association of KIR2DS2 with vasculitis in patients with rheumatoid arthritis has been reported. Because scleroderma is characterized by an involvement of the vascular system, we sought to determine whether KIR2DS2 is associated with scleroderma.Methods: We typed 9 KIR genes in 102 patients with scleroderma and in 100 blood donors, using polymerase chain reaction on genomic DNA.Results: Twelve patients with scleroderma, compared with only 2 blood donors, had KIR phenotypes characterized by the presence of the activating KIR2DS2 and the absence of the corresponding inactivating KIR2DL2 (P = 0.005).Conclusion: The genetic combination of KIR2DS2+ and KIR2DL2− is associated with scleroderma.

Keywords

This publication has 23 references indexed in Scilit:

Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)
The Journal of Experimental Medicine, 2003
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction
Blood, 2002
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Nature Genetics, 2002
Development of a PCR‐SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
Tissue Antigens, 2000
A Role for T Helper 2 Cells in Mediating Skin Fibrosis in Tight-Skin Mice
Cellular Immunology, 1999
Major Histocompatibility Complex Class I Molecules Modulate Activation Threshold and Early Signaling of T Cell Antigen Receptor–γ/δ Stimulated by Nonpeptidic Ligands
The Journal of Experimental Medicine, 1997
A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705.
The Journal of Experimental Medicine, 1996
FAMILIAL SCLERODERMA—EVIDENCE FOR ENVIRONMENTAL VERSUS GENETIC TRIGGER
Rheumatology, 1994
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
The Journal of Experimental Medicine, 1993
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Arthritis & Rheumatism, 1980